Clinical Trial Update: Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance

View source ↗

Summary

Update on a clinical trial evaluating plasma next-generation sequencing to assess and characterize patients with ALK resistance in Non-Small Cell Lung Cancer. R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Addario Lung Cancer Medical Institute | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED | Results posted: 2025-10-02